Crescent Biopharma · 3 hours ago
Director, Clinical Pharmacology
Crescent Biopharma is focused on developing transformative therapies for cancer patients. The Director, Clinical Pharmacology will lead the clinical pharmacology efforts, providing expertise and oversight in pharmacokinetics and regulatory submissions to support the company's research and development programs.
BiotechnologyHealth CareMedical Device
Responsibilities
Serve as the lead clinical pharmacologist on the project team, accountable for clinical pharmacology deliverables, providing subject matter expertise on PK/PD and quantitative pharmacology
Play a pivotal role in planning and executing clinical pharmacology activities to support development programs
Drive utilization of model-based drug development approach for human PK prediction, dose and dosing regimen selection and optimization, collaborating closely with cross functional colleagues
Oversee and/or perform PK/PD data analyses and contribute to the interpretation of study results through all phases of clinical development
Lead preparation and review of clinical pharmacology sections of study protocols, reports, investigators' brochures and regulatory filings (IND’s, BLA’s, etc.), and respond to regulatory inquiries related to clinical pharmacology
Provide oversight to vendors and consultants to ensure timely delivery of high-quality data and reports to support go/no-go decisions and dosing strategy
Assure the implementation and adherence to SOPs, GXPs, and regulatory standards in clinical pharmacology programs
Qualification
Required
PhD in pharmaceutical sciences, pharmacology with a focus on pharmacokinetics and pharmacometrics
Strong understanding of clinical pharmacology study design, data analysis, and regulatory requirements
Minimum 8 years of experience in clinical pharmacology and pharmacometrics, with hands-on experience in PK data analysis
Preferred
Prior experience in the field of ADC development is a plus
Experience in the Oncology therapeutic area is highly desirable
Benefits
100% employer-paid benefits package.
Flexible PTO.
Two, one-week company-wide shutdowns each year.
Access to resources, mentorship, and growth opportunities.
Medical, dental, vision, life insurance, short- and long-term disability.
Company’s savings plan (401(k)).
Company’s long-term incentive program.
Unlimited PTO; Sick time – 10 days per calendar year; Holiday pay, including two Company shut downs; Parental Leave – 16 weeks within one year of the birth/adoption/foster care of a child; FMLA; Military Leave.
Company
Crescent Biopharma
Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.
Funding
Current Stage
Public CompanyTotal Funding
$585MKey Investors
Fairmount Funds Management
2025-12-04Post Ipo Equity· $185M
2025-06-16Post Ipo Equity· $200M
2025-06-16IPO
Recent News
MarketScreener
2025-12-18
2025-12-07
Company data provided by crunchbase